CONNECT Nearsourcing Initiative presents: Bench to Bedside: Doing Business Locally Benefits the Drug Discovery Process

Taking drug discovery from bench to bedside entails a whole suite of steps beyond minimizing costs and staying competitive - adhering to industry standards and being drug and regulatory compliant need to be considered. Join industry leaders from Althea Technologies, Molecular Response Laboratories, Pharmatek Laboratories and Sharp HealthCare as they explore the benefits of staying local when it comes to outsourcing needs in the drug development process and the lessons they learned along the way.